Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 1999 Apr;19(4):212-4.

[Clinical study on acute upper respiratory tract infection treated with qingkailing injection]

[Article in Chinese]
C Li  1 , X Wang, S Chen
Affiliations
  • PMID: 11783268
Clinical Trial

[Clinical study on acute upper respiratory tract infection treated with qingkailing injection]

[Article in Chinese]
C Li et al. Zhongguo Zhong Xi Yi Jie He Za Zhi. 1999 Apr.

Abstract

Objective: To explore the effect of Qingkailing injection (QKLI) in treating acute fever.

Methods: Four hundred cases of acute upper respiratory tract infection were divided into three groups treated with QKLI 120 ml/d, 160 ml/d and 200 ml/d respectively, and compared with a control group treated with lincomycin 1.8 g/d.

Results: The markedly effective rate of QKLI was 84.14% which was better than that of lincomycin (75.83%). The mean initial time of QKLI (12.6 h) was shorter than that of lincomycin (17.6 h). Effect of QKLI on patients with disease course within one day was better than that within 3 days. No significant difference revealed between effects in groups treated with different dosage of QKLI. The effect of QKLI in lowering white blood cell count was similar to that of lincomycin. For patients with positive throat swab culture of pathogenic bacteria, QKLI displayed good antibacterial action in vivo.

Conclusion: QKLI is a highly effective with rapid action drug for treatment of acute respiratory infection.

PubMed Disclaimer

Substances